Showing results (1321-1330 of 3,156) with videos related to

Sort By:
Pageof 316
Neuro-Oncology|July 2, 2021
A comparative integrated multi-omics analysis identifies CA2 as a novel target for chordomaTong Meng, Runzhi Huang, Jiali Jin, et al.
Neuro-Oncology|July 2, 2021
BOLD asynchrony elucidates tumor burden in IDH-mutated gliomasPetros D Petridis, Craig I Horenstein, Brianna Pereira, et al.
Neuro-Oncology|December 30, 2020
Prognostic relevance of clinical and molecular risk factors in children with high-risk medulloblastoma treated in the phase II trial PNET HR+5Christelle Dufour, Stephanie Foulon, Anne Geoffray, et al.
Neuro-Oncology|June 9, 2021
Experimental design of preclinical experiments: number of PDX lines vs subsampling within PDX linesJeanette E Eckel-Passow, Gaspar J Kitange, Paul A Decker, et al.
Neuro-Oncology|July 7, 2021
Preclinical modeling in glioblastoma patient-derived xenograft (GBM PDX) xenografts to guide clinical development of lisavanbulin-a novel tumor checkpoint controller targeting microtubulesDanielle M Burgenske, Surabhi Talele, Jenny L Pokorny, et al.
Neuro-Oncology|October 30, 2020
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017Quinn T Ostrom, Nirav Patil, Gino Cioffi, et al.
Neuro-Oncology|November 1, 2020
Radiological assessment schedule for high-grade glioma patients during the surveillance period using parametric modelingSo Young Ji, Jongjin Lee, Joo Ho Lee, et al.
Neuro-Oncology|July 5, 2022
Combined molecular subtyping, grading, and segmentation of glioma using multi-task deep learningSebastian R van der Voort, Fatih Incekara, Maarten M J Wijnenga, et al.
Neuro-Oncology|July 5, 2022
Fastigial nuclei surgical damage and focal midbrain disruption implicate PAG survival circuits in cerebellar mutism syndromeSamuel S McAfee, Silu Zhang, Ping Zou, et al.
Neuro-Oncology|June 20, 2022
The first-in-human phase I study of a brain-penetrant mutant IDH1 inhibitor DS-1001 in patients with recurrent or progressive IDH1-mutant gliomasAtsushi Natsume, Yoshiki Arakawa, Yoshitaka Narita, et al.
Pageof 316